Dysregulation of insulin signaling may lead to several debilitating disorders such as insulin resistance, metabolic syndrome, type 2 diabetes (T2D), cardiovascular disease, and/or cancer [4–6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.